Exploring actinobacteria to discover new natural products and their biosynthesis
Mining Actinobacterial Genomes for Natural Product Discovery and Biosynthesis
This study is exploring how certain bacteria can create natural substances that might be turned into new medicines, which could help people with different health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11059054 on NIH RePORTER |
What this research studies
This research investigates the genetic potential of actinobacteria to produce natural products that could lead to new drugs and therapies. By utilizing advanced genomic technologies, the team aims to identify and manipulate specific gene clusters responsible for the biosynthesis of these compounds. Patients may benefit from the development of novel medications derived from these natural products, which could address various health conditions. The research involves both laboratory work and computational analysis to uncover the hidden capabilities of these microorganisms.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions that could be treated by novel natural products derived from actinobacteria.
Not a fit: Patients with conditions that are not addressed by natural products or those who do not respond to such treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new medications that improve treatment options for patients.
How similar studies have performed: Previous research has shown success in discovering new natural products through genome mining and genetic manipulation of microorganisms, indicating a promising approach.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Shen, Ben — University of Florida
- Study coordinator: Shen, Ben
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.